Most recent notices

• VPHM

  Date:

  15 July 2008

  Comments:

  0 comments

  What do they do? Are their drugs working?

• July's PICK

  Date:

  23 July 2007

  Comments:

  0 comments

  Guys,
  June’s pick was great! It is improving my profolio great time. CHTP went up to 7.35 at one point, and I was almost have it sold for a 50% return in a month. But I am hoping it will go up to 8.00 since all the clinical study will be in couple months. Anyway, I will stick to the plan. Sell above $7.

  July’s pick is VRTX. It is a very small company. Their focus is VX-950. The clinical trial is in fast track, meaning there is a communication with the FDA. It should start their pharse 3 soon.

  What I like about them: they have profit form a existing drugs. That mean they can do science. They have product until other small biotech

  What I don’t like, the CEO is from Harvard. I talk to some officers, they don’t sounds very intelligent.
  I think this company will be a timely buy and sell.

  Buy below $30, sell above $35.
  Hold up to 1 to 2 year
  Trade on your own risk